# Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study

> **NCT06285396** · NA · RECRUITING · sponsor: **Samuel Lunenfeld Research Institute, Mount Sinai Hospital** · enrollment: 96 (estimated)

## Conditions studied

- Postpartum Hemorrhage

## Interventions

- **DRUG:** Ephedrine
- **DRUG:** Phenylephrine
- **DRUG:** Norepinephrine
- **DRUG:** Oxytocin

## Key facts

- **NCT ID:** NCT06285396
- **Lead sponsor:** Samuel Lunenfeld Research Institute, Mount Sinai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-18
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06285396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06285396, "Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06285396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*